Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. Academic Article uri icon

Overview

publication date

  • September 19, 2011

Research

keywords

  • Breast Neoplasms
  • Enzyme Inhibitors
  • Genes, BRCA1
  • Genes, BRCA2
  • Mutation
  • Poly(ADP-ribose) Polymerase Inhibitors

Identity

Scopus Document Identifier

  • 81155151836

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.36.8134

PubMed ID

  • 21931031

Additional Document Info

volume

  • 29

issue

  • 32